Paris Rethinking Cancer Summit: opening a brave new front
This upcoming world-first cancer summit in Paris looks set to open a new scientific front in the decades-long “War on Cancer” ie the role of diet and metabolism in cancer control. The Rethinking Cancer conference runs on September 21-22, 2017, at the internationally renowned Gustave Roussy Cancer Institute.
It brings together world leaders – top scientists and clinicians working in a vital but under-investigated research area. They are leading what they believe is a major part of the real “revolution” in treatment: anti-angiogenesis methods. Angiogenesis is the term for growth of new blood vessels that cancer needs to survive and thrive.
The conference will, therefore, address three main topics: metabolism, caloric restriction and dietary bioactives.
Organisers are Gustave Roussy Cancer Campus’s Dutch Director General, Dr Alexander Eggermont, and French renal specialist, Dr Bernard Escudier. The visionary behind the summit is Air France captain and cancer survivor Jean-Jacques Trochon.
Foodmed.net has published Trochon’s remarkable health story. In it, he explains why he chose to delay chemotherapy and radiation “intelligently” and instead, opted for anti-angiogenesis therapies.
Trochon believes that the summit will “change the world” for doctors and patients.
All the speakers on the summit programme are exceptional leaders in a paradigm shift around cancer treatment.
Alexander Eggermont has been Professor of Oncology with the status of “Classe Exceptionelle” in the Paris-Sud University since 2012 and Professor of Oncological Surgery at the Erasmus University of Rotterdam (Holland) since 2003.
He also holds a Chair in the International Research Network on cancer at the Erasmus University of Rotterdam. Since 2001, Eggermont has filled the Joseph Maisin Honorary Chair of Oncological Surgery at the Louvain Catholic University in Belgium.
Escudier is a trained cardiologist who moved to the Gustave Roussy Institute in 1983, initially in the Intensive Care Unit. He later led the Immunotherapy Unit, mainly in charge of developing programs in renal cell carcinoma (RCC) and melanoma.
He leads the Gustave Roussy’s renal team. His main fields are RCC, immunotherapy (cytokines, vaccine), and developing new strategies (antiangiogenic drugs, gene therapy). Escudier has also been principal investigator of many RCCs, from phase I to III.
Also on the panel of speakers from France is physician, cancer surgeon and scientist Dr Laurent Schwartz. Schwartz is author of Cancer: A Simple And Non-Toxic Treatment, based on the metabolic model of cancer.
European speakers include Dr Rainer Stange, a physicist and an internist and expert in natural healing and physical therapy since 1984.
Stange is researching at the Institute for Social Medicine, Epidemiology and Health Economics at the Charité University Medical Center in Berlin.
Charité is one of the largest university hospitals in Europe. It proudly lays claim to more than half of all German Nobel Prize winners in Physiology or Medicine.
Since 2001, Stange has been part of the Immanuel Hospital Berlin Department of Natural Medicine and the senior physician since 2009. He works closely with Prof Andreas Michalsen, head physician at Immanuel Hospital Berlin, and Professor of Clinical Naturopathy at Charité……
FoodMed.net: Read the full article
Trackback from your site.